PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
ANBI
Health Insurance Fund has been granted ANBI status by the Dutch Tax and Customs Administration.
The Dutch abbreviation ANBI means Algemeen Nut Beogende Instelling, or Public Benefit Organization. Institutions can only be qualified as a public benefit organization if at least 90% of their efforts are focused on the common good.
In light of revised regulations, organizations with the ANBI status are required by law to publish the information mentioned below on their websites as per 1st of January 2014.
Name of the institution
Stichting Health Insurance Fund, a not-for-profit foundation established under the laws of the Netherlands, with its seat in Amsterdam, hereinafter referred to as Health Insurance Fund or the Foundation.
RSIN/fiscal number
Health Insurance Fund’s RSIN number is 814968727. The Chamber of Commerce number is 34234456.
Contact details
Health Insurance Fund
AHTC, Tower 4C • Paasheuvelweg 251105 BP Amsterdam • The Netherlands
P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
+31 (0)20 210 3920 / info@hifund.org
Objectives
The objectives of the Health Insurance Fund are:
The successful execution of each of the sub-goals should lead to: reducing health and financial risks for low-income families, reducing the financial and operational risk of healthcare providers and insurance companies, reducing the risk of ineffective of aid, and reducing the risk of the consequences of an overcrowded low quality healthcare delivery for governments. And together should achieve its strategic goal of building a healthcare delivery system that functions efficient and effectively over a long-term period.
Policy / Beleidsplan
The Health Insurance Fund policy {“beleidsplan”} is included in the latest Health Insurance Fund Annual Report.
Governance
Health Insurance Fund is managed by the Executive Board of Stichting PharmAccess Group Foundation, which in turn is supervised by the Supervisory Board of Stichting PharmAccess Group Foundation.
The members of the Executive Board and Supervisory Board of Stichting PharmAccess Group Foundation can be viewed here.
Executive Board
Supervisory Board
Remuneration policy
Board members are unpaid. They receive no remuneration or expense allowance. They do have the right to request compensation for costs incurred, such as travel expenses or telephone costs.
Financial accountability
The Foundation’s financial resources may consist of subsidies, donations, bequests, assets acquired by testamentary disposition and any further revenues. The implementation of accounting and preparation of financial statements has been outsourced to Deloitte. The financial statements and explanatory notes are approved each year by the Board and sent to the Ministry of Foreign Affairs and possibly to other donors.